EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Clinical trial NCT07647289 · RECRUITING

Trial details

NCT number: NCT07647289
Sponsor: Peking University Third Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Cancer (MIBC)

Start date: 2025-04-15
Primary completion: 2027-04-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.